Acute Myeloid Leukemia Therapeutics Market | Size, Share, Growth and Forecast by 2027

According to IMARC Group's latest report "Acute Myeloid Leukemia Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.' the global acute myeloid leukemia therapeutics market size reached US$ 954.8 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1947.8 Million by 2027, exhibiting a growth rate (CAGR) of 12.8% during 2022-2027.

Acute myeloid leukemia (AML) is a cancer of bone marrow and blood with excess immature white blood cells. It is characterized by breathlessness, fatigue, discoloration of the skin, high body temperatures, bleeding gums, weight loss, and nosebleeds. AML occurs when a bone marrow cell suddenly develops mutations in its deoxyribonucleic acid (DNA) or genetic material and its primary treatment includes chemotherapy, targeted drug, hormone, and radiation therapies, and stem cell transplant.  

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report

Request for a PDF Sample of this Report: https://www.imarcgroup.com/acute-myeloid-leukemia-therapeutics-market/requestsample

Acute Myeloid Leukemia Therapeutics Market Trends:

The increasing geriatric population and extended exposure to hazardous chemicals are some of the primary factors accelerating the market growth. Moreover, the surging prevalence of leukemia and the rising consumer awareness regarding the availability of AML therapeutics are propelling the market growth. Furthermore, key market players are investing heavily in research and development (R&D) activities to introduce improved monoclonal antibodies, immunotoxins, and multidrug-resistant modulators, offering enhanced results and efficacy, which is creating a positive outlook for the market. This is further supported by the rapid approval of novel and innovative drugs and burgeoning government funding across the globe. Besides this, the improving healthcare infrastructure and rapid adoption of combination and targeted therapies are providing a considerable thrust to the market growth. Other factors, such as the rapidly expanding healthcare sector and significant technological advancements, are bolstering the market growth.

Acute Myeloid Leukemia Therapeutics Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the acute myeloid leukemia therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

Abbvie Inc.
Amgen Inc.
Bristol-Myers Squibb Company
Celgene
Roche Holding AG
Gilead Sciences Inc.
Novartis AG
Pfizer Inc.
Sanofi S.A
Takeda Pharmaceutical Company Limited.

Key Market Segmentation:

Breakup by Treatment Type:

Cytarabine
Anthracycline Drugs
Alkylating Agents
Anti-Metabolites
Tyrosine Kinase Inhibitors
Others

Breakup by Drug Type:

Small Molecule Drugs
Biopharmaceuticals

Breakup by Route of Administration:

Oral
Injectables

Breakup by Region:

North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=3129&flag=E

Note: We are updating our reports, If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key Highlights of the Report:                                                           

Market Performance (2016-2021)
Market Outlook (2022-2027)
Market Trends
Market Drivers and Success Factors
The Impact of COVID-19 on the Global Market
Value Chain Analysis
Structure of the Global Market
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800

About Us:                                                                   

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.